Medical devices, healthcare technology and the business of care
510(k) clearance · K252549

Non-sterile Powder Free Nitrile Examination Glove, Dual Color (White-Green), Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, Xylazine HCl, and Simulated Gastric Acid; Non-sterile Powder Free Nitrile Examination Glove, Dual Color (White-Blue), Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, Xylazine HCl, and Simulated Gastric Acid

Kossan International Sdn Bhd · Decision date Jan 13, 2026

FDA DECISIONK252549

What did the FDA decide?

FDA records K252549 as a 510(k) premarket notification, with a decision dated Jan 13, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Jan 13, 2026

FDA source record

Regulatory record facts

Identifier
K252549
Regulatory pathway
510(k) premarket notification
Product code
LZA
Decision code
SESE
Decision date
Jan 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Polymer Patient Examination Glove.

Product code
LZA
FDA device class
1

FDA decision timeline

  1. K252549 received

    Application receipt date recorded by FDA.

  2. K252549 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LZA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kossan International Sdn Bhd

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shah Alam

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records